• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rational design of cancer-drug combinations.

作者信息

Ramaswamy Sridhar

机构信息

Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.

出版信息

N Engl J Med. 2007 Jul 19;357(3):299-300. doi: 10.1056/NEJMcibr072593.

DOI:10.1056/NEJMcibr072593
PMID:17634467
Abstract
摘要

相似文献

1
Rational design of cancer-drug combinations.癌症药物组合的合理设计。
N Engl J Med. 2007 Jul 19;357(3):299-300. doi: 10.1056/NEJMcibr072593.
2
Synthetic lethal screen identification of chemosensitizer loci in cancer cells.癌细胞中化学增敏剂基因座的合成致死筛选鉴定
Nature. 2007 Apr 12;446(7137):815-9. doi: 10.1038/nature05697.
3
Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.评估金雀异黄素与紫杉醇联合应用对 A549 非小细胞肺癌细胞的抗转移潜力。
Int J Mol Sci. 2018 Feb 27;19(3):661. doi: 10.3390/ijms19030661.
4
Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer.紫草素通过抑制 NEAT1 和 Akt 信号通路治疗紫杉醇耐药的非小细胞肺癌。
Mol Med. 2020 Apr 8;26(1):28. doi: 10.1186/s10020-020-00152-8.
5
Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301.每周一次纳米白蛋白结合型紫杉醇用于既往治疗过的晚期非小细胞肺癌的II期试验：熊本胸部肿瘤学研究组（KTOSG）试验1301
Lung Cancer. 2016 Sep;99:41-5. doi: 10.1016/j.lungcan.2016.06.009. Epub 2016 Jun 14.
6
Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.紫杉醇联合顺铂作为晚期非小细胞肺癌一线化疗的I/II期研究：初步结果
Semin Oncol. 1995 Dec;22(6 Suppl 15):29-33.
7
Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.一项多中心 1-2a 期剂量递增研究，评估卡培他滨联合卡铂和紫杉醇作为晚期非小细胞肺癌一线治疗的疗效。
J Thorac Oncol. 2009 Nov;4(11):1389-96. doi: 10.1097/JTO.0b013e3181b6b84b.
8
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.XPO1 依赖的核输出是 KRAS 突变型肺癌中的一个可药物靶向的弱点。
Nature. 2016 Oct 6;538(7623):114-117. doi: 10.1038/nature19771. Epub 2016 Sep 28.
9
How might treatment of ALK-positive non-small cell lung cancer change in the near future?
Expert Rev Anticancer Ther. 2016 Oct;16(10):997-9. doi: 10.1080/14737140.2016.1226138. Epub 2016 Aug 25.
10
An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial.IFCT-0002 试验中用于早期肺癌的细胞凋亡甲基化预后标志物。
Clin Cancer Res. 2012 May 15;18(10):2976-86. doi: 10.1158/1078-0432.CCR-11-2797. Epub 2012 Mar 20.

引用本文的文献

1
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies.用于更个性化治疗的高级别神经内分泌肿瘤的患者源性类肿瘤
NPJ Precis Oncol. 2024 Mar 1;8(1):59. doi: 10.1038/s41698-024-00549-2.
2
Mitochondrial metabolism as a target for acute myeloid leukemia treatment.线粒体代谢作为急性髓系白血病治疗的靶点
Cancer Metab. 2021 Apr 21;9(1):17. doi: 10.1186/s40170-021-00253-w.
3
Combination of light-driven co-delivery of chemodrugs and plasmonic-induced heat for cancer therapeutics using hybrid protein nanocapsules.
利用杂化蛋白纳米胶囊实现光驱动化学药物共递送和等离子体诱导热联合用于癌症治疗。
J Nanobiotechnology. 2019 Oct 15;17(1):106. doi: 10.1186/s12951-019-0538-3.
4
Prediction of disease-gene-drug relationships following a differential network analysis.基于差异网络分析的疾病-基因-药物关系预测。
Cell Death Dis. 2016 Jan 14;7(1):e2040. doi: 10.1038/cddis.2015.393.
5
Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma.蛋白质相互作用网络的拓扑鲁棒性分析揭示了克服胶质瘤化疗耐药性的关键靶点。
Sci Rep. 2015 Nov 19;5:16830. doi: 10.1038/srep16830.
6
Efficacy-oriented compatibility for component-based Chinese medicine.基于组分的中药功效导向配伍
Acta Pharmacol Sin. 2015 Jun;36(6):654-8. doi: 10.1038/aps.2015.8. Epub 2015 Apr 13.
7
Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine.骨髓来源的巨噬细胞对化疗药物反应产生白细胞介素-1β：阿霉素和长春新碱的协同作用
Cancer Biol Ther. 2014 Oct;15(10):1395-403. doi: 10.4161/cbt.29922. Epub 2014 Jul 21.
8
Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer.基于图像的药物分析计算预测协同药物组合：在三阴性乳腺癌中的应用。
Mol Oncol. 2014 Dec;8(8):1548-60. doi: 10.1016/j.molonc.2014.06.007. Epub 2014 Jun 19.
9
Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways.靶向抑制网络：预测可靶向药物靶点的选择性组合，以阻断癌症存活途径。
PLoS Comput Biol. 2013;9(9):e1003226. doi: 10.1371/journal.pcbi.1003226. Epub 2013 Sep 12.
10
Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles.面向多靶点抗癌治疗的网络药理学策略：从计算模型到实验设计原则
Curr Pharm Des. 2014;20(1):23-36. doi: 10.2174/13816128113199990470.